Thermal Ablation vs Surgery for Localized Kidney Cancer: a Surveillance, Epidemiology, and End Results (SEER) Database Analysis
Toni K. Choueiri(Harvard University), Jim C. Hu(Presbyterian Hospital), Stephen B. Williams(Cedars-Sinai Medical Center), Stuart R. Lipsitz(Brigham and Women's Hospital), Nathanael D. Hevelone(Brigham and Women's Hospital), Paul L. Nguyen(Beth Israel Deaconess Medical Center), Fabio A. Schutz(Beneficência Portuguesa de São Paulo), Stuart G. Silverman(Brigham and Women's Hospital)
Cited by 96
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k